Supplementary Figure S1 from Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
<p>Treemap of most common drug mechanisms for patients treated in biomarker-matched studies.</p>
সংরক্ষণ করুন:
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
SPIRIT schedule of enrollment, interventions, and assessment.
অনুযায়ী: Kim Christin Honselmann (21176936)
প্রকাশিত: (2025) -
Participant timeline: Schedule of enrollment, interventions, and assessments.
অনুযায়ী: Pierre Angelvy (22683450)
প্রকাশিত: (2025) -
A table showing the clinical participants who were enrolled in a further or higher education course and their research activity and self-declared involvement.
অনুযায়ী: Zoe Edwards (3823528)
প্রকাশিত: (2025) -
Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases
অনুযায়ী: James S. Wilmott (15008931)
প্রকাশিত: (2025) -
Supplementary Tables S1-7 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases
অনুযায়ী: James S. Wilmott (15008931)
প্রকাশিত: (2025)